Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

Business Leaders

Aktuelle NewsUnternehmenMärkteWirtschaft & ForexRohstoffeZinssätzeBusiness LeadersInstitutionelle AnlegerTermineSektoren 
HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien
Portrait de Fred Ehrenkranz Cohen
Alter : 64
Vermögen : 9 216 714 USD
Größte Unternehmen : Intellia Therapeutics, Inc. - Progyny, Inc. - CareDx, Inc - UroGen Pharma Ltd.
Übersicht 
Founder of 5 different companies, notably: Kyverna Therapeutics, Inc., TPG Biotechnology Partners LP and Cell Design Labs, Inc. Fred Ehrenkranz Cohen is an entrepreneur and presently holds the position of Senior Managing Director at VV Manager LLC (which he founded in 2017), Chairman for Cell Design Labs, Inc. (which he founded in 2016) and Managing Director & Partner at Tarrant Capital IP LLC.

He is also Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Member of Association of American Physicians, Member of American Society for Clinical Investigation and Member of National Academy of Medicine and on the board of 14 other companies.

He previously was Director at Rapid Micro Biosystems, Inc., Senior Director-Business Development at Kosan Biosciences, Inc., Managing Director at The Plastics Group, Inc., Managing Director & Partner at TPG Biotechnology Partners LP (he founded the company in 2001), Senior Managing Partner at Vida Ventures LLC (he founded the company in 2017), Advisor at CHV Capital, Inc., Partner at TPG Capital LLC and Professor at The University of California, San Francisco.

Dr. Cohen received an undergraduate degree from Yale University, a doctorate from the University of Oxford and a doctorate from Stanford University.


Aktuelle Stellungen und Verantwortungsbereiche Fred Ehrenkranz Cohen 
NameTitel Seit
Intellia Therapeutics, Inc.
(Biotechnologie)
Independent Director 2019
Progyny, Inc.
( Managed Health Care )
Independent Director 2015
CareDx, Inc
(Biotechnologie)
Independent Director 2003
UroGen Pharma Ltd.
(Biotechnologie)
Independent Director 2017
Cell Design Labs, Inc. Chairman 2016
Tarrant Capital IP LLC Managing Director & Partner 2013
Novotech (Australia) Pty Ltd. Director -
Matrix Pharmaceuticals, Inc. Director -
Quintiles Transnational Corp. Director -
Autistica Trustee -
UCSF Foundation Director 1987
Acumen, Inc. Director -
Kyverna Therapeutics, Inc. Director -
Acrostar Pharmaservices Corp. Director 2017
Novotech Aus Holdco Pty Ltd. Director 2018
Novotech Health Holdings Ltd. Non-Executive Director 2020
Association of American Physicians Member 1995
American Society for Clinical Investigation Member 1990
National Academy of Medicine Member -
National Academy of Medicine (United States) Member 2004
American Academy of Arts & Sciences Member 2008
VV Manager LLC Co-Founder and Senior Managing Director 2017


Anteile an Fred Ehrenkranz Cohen 
NameAktien%Wert
CareDx, Inc (CDNA)
(Biotechnologie)
107 0200,20%4 867 270 USD
Intellia Therapeutics, Inc. (NTLA)
(Biotechnologie)
32 0940,043%3 794 795 USD
Veracyte, Inc. (VCYT)
(Biotechnologie)
10 0000,014%412 000 USD
UroGen Pharma Ltd. (URGN)
(Biotechnologie)
15 0000,067%142 650 USD
Progyny, Inc. (PGNY)
( Managed Health Care )
00,0000%0 USD


Fred Ehrenkranz Cohen: Persönliches Netzwerk 
Meistgelesene News 
18.01.ELON MUSK : Telsa-Investoren drängen Richter, Musk zur Rückzahlung von 13 Mrd. Dollar für SolarCity-Deal anzuweisen
MR
11.01.JAMIE DIMON : JPMorgan's Dimon sagt, dass es 6-9 Monate dauern kann, bis sich das Wachstum der Verbraucherkredite wieder normalisiert
MR
14.01.JACK DORSEY : Jack Dorseys Block will ein offenes Bitcoin-Schürfsystem aufbauen
MR
14.01.ELON MUSK : Tesla-Waren können mit Dogecoin gekauft werden, sagt Musk in einem Tweet
MR
10.01.BRUNELLO CUCINELLI : Luxuskonzern Cucinelli verzeichnet 31% Umsatzplus im Jahr 2021
MR
07.01.CHRISTIAN KLEIN : Deutschlands Vorzeige-Tech-Konzern am Scheideweg
DP
07.01.TIM COOK : Apple-Chef Cook erhält für 2020 fast 100 Millionen Dollar
RE
12.01.MARTIN SORRELL : Sorrells S4 übertrifft die Prognosen bei weitem
MR
12.01.GORDON RISKE : Mit neuem Chef ins neue Jahr
DP
10.01.PAUL SCHULER : Jahresumsatz von 9,15 Milliarden Franken erwartet
AW
Weitere Nachrichten und Newsletter


© 2022 People and Ownership :   
Fred Ehrenkranz Cohen : Verbindungen